Despite Early Promise GLP-1 Disappoints in Parkinson’s ...Middle East

Medscape - News
Despite Early Promise GLP-1 Disappoints in Parkinson’s
Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 study suggesting a potential role for GLP-1 agonists in PD. Medscape Medical News

Hence then, the article about despite early promise glp 1 disappoints in parkinson s was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Despite Early Promise GLP-1 Disappoints in Parkinson’s )

Apple Storegoogle play

Last updated :

Also on site :